143 related articles for article (PubMed ID: 26133969)
21. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo effectiveness evaluation of balofloxacin in experimental Staphylococcus aureus keratitis.
Jiang H; Han S; Guo C; Liu T; Wu X
J Ocul Pharmacol Ther; 2014 Aug; 30(6):482-8. PubMed ID: 24828089
[TBL] [Abstract][Full Text] [Related]
23. Topical Vancomycin 5% Is More Efficacious Than 2.5% and 1.25% for Reducing Viable Methicillin-Resistant Staphylococcus aureus in Infectious Keratitis.
Romanowski EG; Romanowski JE; Shanks RMQ; Yates KA; Mammen A; Dhaliwal DK; Jhanji V; Kowalski RP
Cornea; 2020 Feb; 39(2):250-253. PubMed ID: 31658169
[TBL] [Abstract][Full Text] [Related]
24. Preparation and in vitro/in vivo evaluations of novel ocular micelle formulations of hesperetin with glycyrrhizin as a nanocarrier.
Zhang F; Chen H; Lan J; Song K; Wu X
Exp Eye Res; 2021 Jan; 202():108313. PubMed ID: 33080302
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
[TBL] [Abstract][Full Text] [Related]
26. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
Jensen H; Zerouala C; Carrier M; Short B
J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
[TBL] [Abstract][Full Text] [Related]
27. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Tas T; Kucukbayrak A; Hakyemez IN; Mengeloglu FZ; Simavli H; Ozyalvacli G; Erdurmus M
Cornea; 2013 Jul; 32(7):1052-7. PubMed ID: 23665649
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.
Wu X; Jiang H; Xu Y; Yue W; Yang L; Song Z; Chen H; Liu T
J Ocul Pharmacol Ther; 2012 Aug; 28(4):420-7. PubMed ID: 22360669
[TBL] [Abstract][Full Text] [Related]
29. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME
Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656
[TBL] [Abstract][Full Text] [Related]
30. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis.
Parmar P; Salman A; Kalavathy CM; Kaliamurthy J; Prasanth DA; Thomas PA; Jesudasan CA
Am J Ophthalmol; 2006 Feb; 141(2):282-286. PubMed ID: 16458681
[TBL] [Abstract][Full Text] [Related]
31. Comparative studies for ciprofloxacin hydrochloride pre-formed gels and thermally triggered (in situ) gels: in vitro and in vivo appraisal using a bacterial keratitis model in rabbits.
Abdelkader H; Mansour HF
Pharm Dev Technol; 2015 Jun; 20(4):410-6. PubMed ID: 24392945
[TBL] [Abstract][Full Text] [Related]
32. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P
AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935
[TBL] [Abstract][Full Text] [Related]
33. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride.
Balasubramaniam J; Pandit JK
Drug Deliv; 2003; 10(3):185-91. PubMed ID: 12944139
[TBL] [Abstract][Full Text] [Related]
34. Ex vivo efficacy of gemifloxacin in experimental keratitis induced by methicillin-resistant Staphylococcus aureus.
Marino A; Blanco AR; Ginestra G; Nostro A; Bisignano G
Int J Antimicrob Agents; 2016 Oct; 48(4):395-400. PubMed ID: 27554440
[TBL] [Abstract][Full Text] [Related]
35. Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.
Balzli CL; Caballero AR; Tang A; Weeks AC; O'Callaghan RJ
J Cataract Refract Surg; 2010 Dec; 36(12):2160-7. PubMed ID: 21111321
[TBL] [Abstract][Full Text] [Related]
36. Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones.
Gade SK; Shivshetty N; Sharma N; Bhatnagar S; Garg P; Venuganti VVK
J Ocul Pharmacol Ther; 2018 Oct; 34(8):570-578. PubMed ID: 30136888
[TBL] [Abstract][Full Text] [Related]
37. Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model.
Sensoy D; Cevher E; Sarici A; Yilmaz M; Ozdamar A; Bergişadi N
Eur J Pharm Biopharm; 2009 Aug; 72(3):487-95. PubMed ID: 19223014
[TBL] [Abstract][Full Text] [Related]
38. Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery.
Solomon R; Donnenfeld ED; Perry HD; Rubinfeld RS; Ehrenhaus M; Wittpenn JR; Solomon KD; Manche EE; Moshirfar M; Matzkin DC; Mozayeni RM; Maloney RK
Am J Ophthalmol; 2007 Apr; 143(4):629-34. PubMed ID: 17320811
[TBL] [Abstract][Full Text] [Related]
39. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
[TBL] [Abstract][Full Text] [Related]
40. Bacterial keratitis after nonpenetrating glaucoma surgery.
Mendrinos E; Dreifuss S; Dosso A; Baglivo E; Shaarawy T
J Cataract Refract Surg; 2008 Apr; 34(4):707-9. PubMed ID: 18361998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
